PP
DNLI icon

PDT Partners’s Denali Therapeutics DNLI Stock Holding History

PDT Partners’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-158,384
Closed -$3.68M – 745
2024
Q2 		$3.68M Hold
158,384
– – 0.35% 72
2024
Q1 		$3.25M Buy
158,384
+125,484
+381% +$2.36M 0.31% 98
2023
Q4 		$706K Buy
+32,900
New +$652K 0.08% 349
2022
Q4 		– Sell
-30,588
Closed -$939K – 697
2022
Q3 		$939K Sell
30,588
-5,753
-16% -$187K 0.14% 241
2022
Q2 		$1.07M Buy
36,341
+18,491
+104% +$484K 0.09% 372
2022
Q1 		$574K Buy
+17,850
New +$614K 0.05% 538
2021
Q4 		– Sell
-15,200
Closed -$767K – 902
2021
Q3 		$767K Buy
15,200
+10,466
+221% +$590K 0.06% 397
2021
Q2 		$371K Sell
4,734
-17,531
-79% -$1.08M 0.02% 574
2021
Q1 		$1.27M Buy
22,265
+4,552
+26% +$305K 0.09% 326
2020
Q4 		$1.48M Sell
17,713
-54,224
-75% -$3.28M 0.1% 271
2020
Q3 		$2.58M Buy
71,937
+13,537
+23% +$408K 0.17% 191
2020
Q2 		$1.41M Sell
58,400
-18,300
-24% -$430K 0.1% 242
2020
Q1 		$1.34M Buy
76,700
+38,797
+102% +$809K 0.11% 194
2019
Q4 		$660K Sell
37,903
-1,409
-4% -$23.5K 0.04% 361
2019
Q3 		$602K Buy
39,312
+28,092
+250% +$537K 0.04% 325
2019
Q2 		$233K Buy
+11,220
New +$251K 0.01% 357

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

PDT Partners's DNLI Position: Q3 2024 in Review

PDT Partners sold out of Denali Therapeutics (DNLI) in Q3 2024, closing a stake of 158,384 shares — an estimated $3.68M sold.

PDT Partners first reported a position in DNLI in Q2 2019 and held it in 16 quarters. The position peaked at $3.68M in Q2 2024. 217 funds tracked by Wall St. Rank hold DNLI as of Q3 2024.

  • PDT Partners reported no remaining Denali Therapeutics position as of Q3 2024 after selling out during the quarter.
  • PDT Partners sold 158,384 Denali Therapeutics shares in Q3 2024, an estimated $3.68M.
  • PDT Partners first reported a position in Denali Therapeutics in Q2 2019 and held it in 16 quarters.
  • PDT Partners's Denali Therapeutics position peaked at $3.68M in Q2 2024.
  • 217 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2024.

Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.